MFG
WST icon

Merit Financial Group’s West Pharmaceutical WST Stock Holding History

Merit Financial Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.64M Buy
4,582
+49
+1% +$15K 0.01% 840
2026
Q1 		$1.14M Sell
4,533
-1,040
-19% -$259K 0.01% 925
2025
Q4 		$1.53M Buy
5,573
+3,463
+164% +$947K 0.01% 749
2025
Q3 		$554K Buy
+2,110
New +$513K 0.01% 1125

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Merit Financial Group's WST Position: Q2 2026 in Review

Merit Financial Group increased its West Pharmaceutical (WST) stake by 1.1% in Q2 2026, buying an estimated $15K and bringing the position to 4,582 shares worth $1.64M. The position accounts for 0.01% of the portfolio, ranked #840.

Merit Financial Group first reported a position in WST in Q3 2025 and has held it in 4 quarters since. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Merit Financial Group held 4,582 shares of West Pharmaceutical worth $1.64M as of Q2 2026.
  • Merit Financial Group bought 49 West Pharmaceutical shares in Q2 2026, an estimated $15K.
  • West Pharmaceutical made up 0.01% of Merit Financial Group's portfolio in Q2 2026, its #840 holding.
  • Merit Financial Group first reported a position in West Pharmaceutical in Q3 2025 and has held it in 4 quarters since.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.